!
  + 
* Contact
* !Language
* R&D Strategy
* /
ABM
A Brain Medicine R&D Platform
About Us
ABM Therapeutics is a leading innovative drug discovery company focusing on small molecule targeted therapy for the possible treatments of brain cancers including GBM, as well as brain metastasis from lung cancer, breast cancer and melanoma. Founded by an experienced group of scientists and entrepreneurs with successful track record, we are committed to diligently search and deliver best-in-class and first-in-class medicines for the needed patients worldwide.
News
ABM Therapeutics will present the interim results of its ongoing ABM-1310 Phase 1 trial in...
2024-09-06
Meet ABM Therapeutics at ASCO Annual Meeting 2024...
2024-05-28
ABM Therapeutics 2 Posters at AACR 2024 are Available to Share...
2024-04-12
© 2019 Wall Calvin technology.Powered by Webfoss.
|